Provided by Tiger Trade Technology Pte. Ltd.

Zosano Pharma

0.5576
0.0000
Volume:- -
Turnover:- -
Market Cap:2.73M
PE:-0.04
High:0.5576
Open:0.5576
Low:0.5576
Close:0.5576
52wk High:37.45
52wk Low:0.4600
Shares:4.90M
Float Shares:4.63M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-15.6859
EPS(LYR):-9.3462
ROE:-192.97%
ROA:-41.86%
PB:0.19
PE(LYR):-0.06

Loading ...

Aug 26, 2019

Major Issues Report

Current report, item 1.02
Aug 19, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Aug 14, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 14, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Aug 14, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Jul 22, 2019

Major Issues Report

Current report, item 5.07
Jul 18, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 18, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 18, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 18, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 18, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 31, 2019

Major Issues Report

Current report, items 4.01, 5.02, and 9.01
May 14, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 14, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Mar 25, 2019

Correspondence

[Cover]Correspondence
Feb 28, 2019

Major Issues Report

[Amend] Current report, item 5.02
Mar 28, 2018

[Amend]Public Prospectus